Tuberous sclerosis complex-associated angiomyolipomas: Focus on mTOR inhibition

American Journal of Kidney Diseases

Volumn 59, Issue 2, 2012, Pages 276-283

  Budde, Klemens ^a   Gaedeke, Jens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Mammalian target of rapamycin (mTOR)

Indexed keywords

EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ANGIOMYOLIPOMA; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; BLEEDING; CANCER RISK; CELLULITIS; CLINICAL OBSERVATION; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE ASSOCIATION; FATIGUE; GENE DELETION; GENE MUTATION; HAMARTOMA; HEMANGIOFIBROMA; HUMAN; HYDROCEPHALUS; INFECTION; KIDNEY ADENOMA; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY INJURY; METABOLIC DISORDER; MOUTH ULCER; NEPHRON SPARING SURGERY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL EDEMA; PYELONEPHRITIS; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; STOMATITIS; TREATMENT RESPONSE; TUBEROUS SCLEROSIS COMPLEX; TUMOR VOLUME; ULTRASOUND; UPPER RESPIRATORY TRACT INFECTION;

ANGIOMYOLIPOMA; HUMANS; KIDNEY NEOPLASMS; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 84855854520     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.10.013     Document Type: Review

References (50)

1. A. Astrinidis, E.P. Henske Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease Oncogene 24 2005 7475 7481 (Pubitemid 41637987)
2. H.J. Baskin Jr The pathogenesis and imaging of the tuberous sclerosis complex Pediatr Radiol 38 2008 936 952
3. P.B. Crino, K.L. Nathanson, E.P. Henske The tuberous sclerosis complex N Engl J Med 355 2006 1345 1356
4. J.P. Osborne, A. Fryer, D. Webb Epidemiology of tuberous sclerosis Ann N Y Acad Sci 615 1991 125 127
5. F.E. Jansen, O. van Nieuwenhuizen, A.C. van Huffelen Tuberous sclerosis complex and its founders [abstract] J Neurol Neurosurg Psychiatry 75 2004 770 (Pubitemid 38526692)
6. M. van Slegtenhorst, R. de Hoogt, C. Hermans Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 Science 277 1997 805 808 (Pubitemid 27366729)
7. The European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterisation of the tuberous sclerosis gene on chromosome 16 Cell 75 1993 1305 1315
8. The European Polycystic Kidney Disease Consortium The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 Cell 77 1994 881 894
9. P.J. de Vries, P.F. Bolton Genotype-phenotype correlations in tuberous sclerosis [abstract] J Med Genet 37 2000 E3
10. O. Sancak, M. Nellist, M. Goedbloed Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex Eur J Hum Genet 13 2005 731 741 (Pubitemid 40846845)
11. V. Napolioni, P. Curatolo Genetics and molecular biology of tuberous sclerosis complex Curr Genomics 9 2008 475 487
12. D.J. Kwiatkowski Tuberous sclerosis: from tubers to mTOR Ann Hum Genet 67 2003 87 96 (Pubitemid 38312854)
13. K. Inoki, Y. Li, T. Xu, K.-L. Guan Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling Genes Dev 17 2003 1829 1834 (Pubitemid 36944560)
14. Q. Yang, K.-L. Guan Expanding mTOR signaling Cell Res 17 2007 666 681 (Pubitemid 47255937)
15. M.A. Bjornsti, P.J. Houghton The TOR pathway: a target for cancer therapy Nat Rev Cancer 4 2004 335 348 (Pubitemid 38579480)
16. S. Wullschleger, R. Loewith, M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484 (Pubitemid 43199434)
17. K.A. Orlova, P.B. Crino The tuberous sclerosis complex Ann N Y Acad Sci 1184 2010 87 105
18. J. Ma, Y. Meng, D.J. Kwiatkowski Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade J Clin Invest 120 2010 103 114
19. M. Karbowniczek, D. Zitserman, D. Khabibullin The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development J Clin Invest 120 2010 93 102
20. K. Inoki, Y. Li, T. Zhu, J. Wu, K.-L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat Cell Biol 4 2002 648 657 (Pubitemid 34993700)
21. H.C. Dan, M. Sun, L. Yang Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin J Biol Chem 277 2002 35364 35370
22. E.A. Goncharova, D.A. Goncharov, A. Eszterhas Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM) J Biol Chem 277 2002 30958 30967 (Pubitemid 34970798)
23. J.A. Chan, H. Zhang, P.S. Roberts Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation J Neuropathol Exp Neurol 63 2004 1236 1242 (Pubitemid 39603395)
24. S.K. Rakowski, E.B. Winterkorn, E. Paul, D.J.R. Steele, E.F. Halpern, E.A. Thiele Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors Kidney Int 70 2006 1777 1782 (Pubitemid 44684809)
25. M.E. Adriaensen, C.M. Schaefer-Prokop, T. Stijnen, D.A. Duyndam, B.A. Zonnenberg, M. Prokop Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature Eur J Neurol 16 2009 691 696
26. P. Curatolo, R. Bombardieri, S. Jozwiak Tuberous sclerosis Lancet 372 2008 657 668
27. T.P. Habif Cutaneous manifestations of internal disease Clinical Dermatology 5th ed. 2010 Elsevier Inc London, England
28. E.S. Roach, M.R. Gomez, H. Northrup Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria J Child Neurol 13 1998 624 628 (Pubitemid 29035481)
29. H. Northrup, K.S. Au Tuberous sclerosis complex In: Pagon RA, Bird TC, Dolan CR, Stephens K, eds. GeneReviews. Seattle, WA: University of Washington http://www.ncbi.nlm.nih.gov/books/NBK1220/ Accessed July 27, 2011
30. F.J. O'Callaghan, M.J. Noakes, C.N. Martyn, J.P. Osborne An epidemiological study of renal pathology in tuberous sclerosis complex BJU Int 94 2004 853 857 (Pubitemid 39472484)
31. J.R. Sampson, M.M. Maheshwar, R. Aspinwall Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene Am J Hum Genet 61 1997 843 851 (Pubitemid 27418458)
32. E.P. Henske The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked? Curr Mol Med 4 2004 825 831 (Pubitemid 39585727)
33. J. Bjornsson, M.P. Short, D.J. Kwiatkowski, E.P. Henske Tuberous sclerosis-associated renal cell carcinoma Clinical, pathological, and genetic features Am J Pathol 149 1996 1201 1208 (Pubitemid 26337239)
34. C.W. Shepherd, M.R. Gomez, J.T. Lie, C.S. Crowson Causes of death in patients with tuberous sclerosis Mayo Clin Proc 66 1991 792 796
35. J.J. Bissler, J.C. Kingswood Renal angiomyolipomata Kidney Int 66 2004 924 934 (Pubitemid 39120994)
36. D.S. Kellner, M.C. Ercolani, G. Isom-Batz, D.J. Javit, N.A. Armenakas Renal angiomyolipoma presenting with massive retroperitoneal hemorrhage Hosp Physician 40 2004 34 36
37. A. Clarke, E. Hancock, C. Kingswood, J.P. Osborne End-stage renal failure in adults with the tuberous sclerosis complex Nephrol Dial Transplant 14 1999 988 991 (Pubitemid 29155165)
38. D.E. Maziak, S. Kesten, D.C. Rappaport, J. Maurer Extrathoracic angiomyolipomas in lymphangioleiomyomatosis Eur Respir J 9 1996 402 405 (Pubitemid 126575946)
39. T. Carsillo, A. Astrinidis, E.P. Henske Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis Proc Natl Acad Sci U S A 97 2000 6085 6090 (Pubitemid 30367527)
40. M. Karbowniczek, A. Astrinidis, B.R. Balsara Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism Am J Respir Crit Care Med 167 2003 976 982 (Pubitemid 36408163)
41. A. Corsenca, F. Aebersold, H. Moch Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages Nephrol Dial Transplant 22 2007 3330 3333 (Pubitemid 350202589)
42. E. Lesma, V. Grande, S. Carelli Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor Am J Pathol 167 2005 1093 1103 (Pubitemid 41416260)
43. L. Lee, P. Sudentas, B. Donohue Efficacy of a rapamycin analog (CCI-779) and IFN-γ in tuberous sclerosis mouse models Genes Chromosomes Cancer 42 2005 213 227 (Pubitemid 40171186)
44. I. Herry, C. Neukirch, M.-P. Debray, F. Mignon, B. Crestani Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex Eur J Intern Med 18 2007 76 77 (Pubitemid 46091655)
45. J.J. Bissler, F.X. McCormack, L.R. Young Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis N Engl J Med 358 2008 140 151
46. D.M. Davies, P.J. de Vries, S.R. Johnson Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial Clin Cancer Res 17 2011 4071 4081
47. G.F.L. Hofbauer, A. Marcollo-Pini, A. Corsenca The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis Br J Dermatol 159 2008 473 475 (Pubitemid 352009863)
48. J.M. Morton, C. McLean, S.S. Booth, G.I. Snell, H.M. Whitford Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment J Heart Lung Transplant 27 2008 462 465 (Pubitemid 351418242)
49. D.A. Krueger, M.M. Care, K. Holland Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis N Engl J Med 363 2010 1801 1811
50. M.K. Koenig, I.J. Butler, H. Northrup Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex J Child Neurol 23 2008 1238 1239